Cargando…

USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016

Methicillin-resistant Staphylococcus aureus (MRSA) USA300 isolates have been recognized globally, not only in community but also in healthcare settings. USA300 isolates were initially resistant only to methicillin, but resistance to non-β-lactams has emerged with time. To evaluate the prevalence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Enström, Josefine, Fröding, Inga, Giske, Christian G., Ininbergs, Karolina, Bai, Xiangning, Sandh, Gustaf, Tollström, Ulla-Britt, Ullberg, Måns, Fang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221263/
https://www.ncbi.nlm.nih.gov/pubmed/30403684
http://dx.doi.org/10.1371/journal.pone.0205761
_version_ 1783368982357606400
author Enström, Josefine
Fröding, Inga
Giske, Christian G.
Ininbergs, Karolina
Bai, Xiangning
Sandh, Gustaf
Tollström, Ulla-Britt
Ullberg, Måns
Fang, Hong
author_facet Enström, Josefine
Fröding, Inga
Giske, Christian G.
Ininbergs, Karolina
Bai, Xiangning
Sandh, Gustaf
Tollström, Ulla-Britt
Ullberg, Måns
Fang, Hong
author_sort Enström, Josefine
collection PubMed
description Methicillin-resistant Staphylococcus aureus (MRSA) USA300 isolates have been recognized globally, not only in community but also in healthcare settings. USA300 isolates were initially resistant only to methicillin, but resistance to non-β-lactams has emerged with time. To evaluate the prevalence and antimicrobial susceptibility of USA300 isolates in Stockholm, we conducted a nine-year retrospective study. Of 5359 consecutive MRSA cases in Stockholm, isolates from 285 cases were USA300 strains according to the pulsed-field gel electrophoresis pattern. Of these cases, repeated isolates with altered antibiotic resistance patterns were observed in six individuals. Therefore, antimicrobial susceptibility testing was performed on totally 291 isolates. To study the phylogenetic relatedness of isolates in transmission events and genomic resistance traits, 35 isolates were further studied by whole genome sequencing (WGS). The incidence of MRSA was increased from 17.6 per 100,000 inhabitants in 2008 to 37.3 per 100,000 inhabitants in 2016, while the proportion of USA300 cases declined from 6.6% in 2008 to 2.6% in 2016. Among the USA300 isolates, 73.5% were community-associated, 21.3% healthcare-associated, and 5.2% had unknown acquisition. The highest resistance rate among non-β-lactams was found in erythromycin (86%), followed by fluoroquinolones (68–69%). 57% of the isolates were resistant to both erythromycin and fluoroquinolone. Simultaneous resistance to four non-β-lactam antibiotic classes was found in six isolates. Four isolates were susceptible to all non-β-lactam antibiotics. Ceftaroline, daptomycin, linezolid, mupirocin, rifampicin, teicoplanin, telavancin, trimethoprim-sulfamethoxazole and vancomycin retained full activity in the study. WGS analysis indicated that isolates from an outbreak were phylogenetically closely related. In conclusion, USA300 MRSA isolates in Stockholm have neither been limited to the community setting, nor remained susceptible to non-β-lactam agents. WGS is becoming a useful tool in tracing transmission events. The results herein provide the most up-to-date and comprehensive information regarding status of USA300 strains in this geographic area.
format Online
Article
Text
id pubmed-6221263
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62212632018-11-19 USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016 Enström, Josefine Fröding, Inga Giske, Christian G. Ininbergs, Karolina Bai, Xiangning Sandh, Gustaf Tollström, Ulla-Britt Ullberg, Måns Fang, Hong PLoS One Research Article Methicillin-resistant Staphylococcus aureus (MRSA) USA300 isolates have been recognized globally, not only in community but also in healthcare settings. USA300 isolates were initially resistant only to methicillin, but resistance to non-β-lactams has emerged with time. To evaluate the prevalence and antimicrobial susceptibility of USA300 isolates in Stockholm, we conducted a nine-year retrospective study. Of 5359 consecutive MRSA cases in Stockholm, isolates from 285 cases were USA300 strains according to the pulsed-field gel electrophoresis pattern. Of these cases, repeated isolates with altered antibiotic resistance patterns were observed in six individuals. Therefore, antimicrobial susceptibility testing was performed on totally 291 isolates. To study the phylogenetic relatedness of isolates in transmission events and genomic resistance traits, 35 isolates were further studied by whole genome sequencing (WGS). The incidence of MRSA was increased from 17.6 per 100,000 inhabitants in 2008 to 37.3 per 100,000 inhabitants in 2016, while the proportion of USA300 cases declined from 6.6% in 2008 to 2.6% in 2016. Among the USA300 isolates, 73.5% were community-associated, 21.3% healthcare-associated, and 5.2% had unknown acquisition. The highest resistance rate among non-β-lactams was found in erythromycin (86%), followed by fluoroquinolones (68–69%). 57% of the isolates were resistant to both erythromycin and fluoroquinolone. Simultaneous resistance to four non-β-lactam antibiotic classes was found in six isolates. Four isolates were susceptible to all non-β-lactam antibiotics. Ceftaroline, daptomycin, linezolid, mupirocin, rifampicin, teicoplanin, telavancin, trimethoprim-sulfamethoxazole and vancomycin retained full activity in the study. WGS analysis indicated that isolates from an outbreak were phylogenetically closely related. In conclusion, USA300 MRSA isolates in Stockholm have neither been limited to the community setting, nor remained susceptible to non-β-lactam agents. WGS is becoming a useful tool in tracing transmission events. The results herein provide the most up-to-date and comprehensive information regarding status of USA300 strains in this geographic area. Public Library of Science 2018-11-07 /pmc/articles/PMC6221263/ /pubmed/30403684 http://dx.doi.org/10.1371/journal.pone.0205761 Text en © 2018 Enström et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Enström, Josefine
Fröding, Inga
Giske, Christian G.
Ininbergs, Karolina
Bai, Xiangning
Sandh, Gustaf
Tollström, Ulla-Britt
Ullberg, Måns
Fang, Hong
USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016
title USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016
title_full USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016
title_fullStr USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016
title_full_unstemmed USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016
title_short USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016
title_sort usa300 methicillin-resistant staphylococcus aureus in stockholm, sweden, from 2008 to 2016
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221263/
https://www.ncbi.nlm.nih.gov/pubmed/30403684
http://dx.doi.org/10.1371/journal.pone.0205761
work_keys_str_mv AT enstromjosefine usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016
AT frodinginga usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016
AT giskechristiang usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016
AT ininbergskarolina usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016
AT baixiangning usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016
AT sandhgustaf usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016
AT tollstromullabritt usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016
AT ullbergmans usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016
AT fanghong usa300methicillinresistantstaphylococcusaureusinstockholmswedenfrom2008to2016